91 related articles for article (PubMed ID: 8181665)
21. Transcriptional regulation of Zic3 by heterodimeric AP-1(c-Jun/c-Fos) during Xenopus development.
Lee SY; Lee HS; Moon JS; Kim JI; Park JB; Lee JY; Park MJ; Kim J
Exp Mol Med; 2004 Oct; 36(5):468-75. PubMed ID: 15557819
[TBL] [Abstract][Full Text] [Related]
22. Regulation of the glucocorticoid receptor gene by the AP-1 transcription factor.
Wei P; Vedeckis WV
Endocrine; 1997 Dec; 7(3):303-10. PubMed ID: 9657066
[TBL] [Abstract][Full Text] [Related]
23. The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with Jun: transcription factor AP-1 is comprised of multiple protein complexes.
Cohen DR; Ferreira PC; Gentz R; Franza BR; Curran T
Genes Dev; 1989 Feb; 3(2):173-84. PubMed ID: 2497053
[TBL] [Abstract][Full Text] [Related]
24. Isolation of novel, transcriptionally active AP-1 binding sites: implications for cellular transformation.
Hawker KL; Vass JK; Ozanne BW
Oncogene; 1996 Jul; 13(2):283-92. PubMed ID: 8710367
[TBL] [Abstract][Full Text] [Related]
25. Acetaminophen-induced hepatotoxicity is associated with early changes in AP-1 DNA binding activity.
Blazka ME; Bruccoleri A; Simeonova PP; Germolec DR; Pennypacker KR; Luster MI
Res Commun Mol Pathol Pharmacol; 1996 Jun; 92(3):259-73. PubMed ID: 8827825
[TBL] [Abstract][Full Text] [Related]
26. Possible role for the FosB/JunD AP-1 transcription factor complex in glutamate-mediated excitotoxicity in cultured cerebellar granule cells.
Lidwell K; Griffiths R
J Neurosci Res; 2000 Nov; 62(3):427-39. PubMed ID: 11054812
[TBL] [Abstract][Full Text] [Related]
27. Activation and inhibition of the AP-1 complex in human breast cancer cells.
Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
[TBL] [Abstract][Full Text] [Related]
28. In vivo viral and cellular Jun complexes exhibit differential interaction with a number of in vitro generated 'AP-1- and CREB-like' target sequences.
Hadman M; Loo M; Bos TJ
Oncogene; 1993 Jul; 8(7):1895-903. PubMed ID: 8510933
[TBL] [Abstract][Full Text] [Related]
29. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex.
Soto U; Das BC; Lengert M; Finzer P; zur Hausen H; Rösl F
Oncogene; 1999 May; 18(21):3187-98. PubMed ID: 10359524
[TBL] [Abstract][Full Text] [Related]
30. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
Chuĭkin IA; Lianguzova MS; Pospelov VA
Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
[TBL] [Abstract][Full Text] [Related]
31. Cyclic AMP stimulates a JunD/Fra-2 AP-1 complex and inhibits the proliferation of interleukin-6-dependent cell lines.
Rezzonico R; Loubat A; Lallemand D; Pfarr CM; Far DF; Proudfoot A; Rossi B; Ponzio G
Oncogene; 1995 Sep; 11(6):1069-78. PubMed ID: 7566966
[TBL] [Abstract][Full Text] [Related]
32. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
[TBL] [Abstract][Full Text] [Related]
33. Polyamine depletion is associated with an increase in JunD/AP-1 activity in small intestinal crypt cells.
Patel AR; Wang JY
Am J Physiol; 1999 Feb; 276(2):G441-50. PubMed ID: 9950818
[TBL] [Abstract][Full Text] [Related]
34. AP-1 activity during normal human keratinocyte differentiation: evidence for a cytosolic modulator of AP-1/DNA binding.
Briata P; D'Anna F; Franzi AT; Gherzi R
Exp Cell Res; 1993 Jan; 204(1):136-46. PubMed ID: 8416791
[TBL] [Abstract][Full Text] [Related]
35. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun.
Kerppola TK; Curran T
Oncogene; 1994 Mar; 9(3):675-84. PubMed ID: 8108109
[TBL] [Abstract][Full Text] [Related]
36. Difference in transcriptional regulatory function between c-Fos and Fra-2.
Suzuki T; Okuno H; Yoshida T; Endo T; Nishina H; Iba H
Nucleic Acids Res; 1991 Oct; 19(20):5537-42. PubMed ID: 1945831
[TBL] [Abstract][Full Text] [Related]
37. NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity.
Fujioka S; Niu J; Schmidt C; Sclabas GM; Peng B; Uwagawa T; Li Z; Evans DB; Abbruzzese JL; Chiao PJ
Mol Cell Biol; 2004 Sep; 24(17):7806-19. PubMed ID: 15314185
[TBL] [Abstract][Full Text] [Related]
38. Glutamate receptor agonists increase the expression of Fos, Fra, and AP-1 DNA binding activity in the mammalian brain.
Sonnenberg JL; Mitchelmore C; Macgregor-Leon PF; Hempstead J; Morgan JI; Curran T
J Neurosci Res; 1989 Sep; 24(1):72-80. PubMed ID: 2553994
[TBL] [Abstract][Full Text] [Related]
39. Cooperative DNA binding with AP-1 proteins is required for transformation by EWS-Ets fusion proteins.
Kim S; Denny CT; Wisdom R
Mol Cell Biol; 2006 Apr; 26(7):2467-78. PubMed ID: 16537893
[TBL] [Abstract][Full Text] [Related]
40. Molecular regulation of the human IL-3 gene: inducible T cell-restricted expression requires intact AP-1 and Elf-1 nuclear protein binding sites.
Gottschalk LR; Giannola DM; Emerson SG
J Exp Med; 1993 Nov; 178(5):1681-92. PubMed ID: 8228815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
